Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab
Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab.
International Journal of Oncology.
2012,
41(4),
1204-1212,
ISSN: 1019-6439,
PMID: 22842582,